Plus Therapeutics reported $7.96M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Baxter International USD 3.69B 723M Mar/2026
Cerus USD 100.8M 12.37M Dec/2025
Dr.Reddys Laboratories INR 167.47B 9.16B Mar/2026
Haemonetics USD 282.6M 257.27M Mar/2026
Infinity Pharmaceuticals USD 12.06M 775K Jun/2023
Northwest Biotherapeutics USD 87.9M 3.98M Sep/2025
Plus Therapeutics USD 7.96M 4.36M Mar/2026
Sanofi EUR 30.01B 1.66B Mar/2026
Starpharma Holdings AUD 4.61M 614K Dec/2025
Sun Pharmaceuticals INR 226.22B 7.93B Mar/2026
Teva Pharmaceutical Industries USD 13.53B 76M Mar/2026